Anti-calmodulins and Tricyclic Adjuvants in Pain Therapy Block the TRPV1 Channel
2007

Anti-Calmodulin Drugs Block the TRPV1 Channel

Sample size: 22 publication 10 minutes Evidence: moderate

Author Information

Author(s): Oláh Zoltán, Jósvay Katalin, Pecze László, Letoha Tamás, Babai Norbert, Budai Dénes, Ötvös Ferenc, Szalma Sándor, Vizler Csaba

Primary Institution: Institute of Biochemistry, Biological Research Center of the Hungarian Academy of Sciences, Szeged, Hungary

Hypothesis

Calmodulin inhibitors might not enter the cell but inhibit the pore opening of the TRPV1 channel directly at the cation filter site.

Conclusion

The study found that various calmodulin antagonists can directly block the TRPV1 channel, suggesting a new mechanism for their analgesic effects.

Supporting Evidence

  • Calmodulin antagonists inhibited capsaicin-induced Ca2+-uptake in TRPV1 expressing cells.
  • Calmidazolium was the most effective calmodulin antagonist in blocking TRPV1.
  • Calmidazolium significantly reduced heat-evoked responses in spinal dorsal horn neurons.

Takeaway

Some medicines that usually help with mental health can also block pain signals in the body by stopping a specific channel from working.

Methodology

Functional assays were performed on TRPV1 expressing cells to measure Ca2+-uptake in response to capsaicin in the presence of calmodulin inhibitors.

Limitations

The study primarily focused on in vitro and animal models, which may not fully translate to human responses.

Participant Demographics

The study involved embryonic rat dorsal root ganglia cultures and laminectomized rats.

Statistical Information

P-Value

p<0.01

Statistical Significance

p<0.01

Digital Object Identifier (DOI)

10.1371/journal.pone.0000545

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication